Prenatal Exposure to ADHD Meds Tied to Neonatal Morbidity

This article originally appeared here.
Share this content:
Prenatal Exposure to ADHD Meds Tied to Neonatal Morbidity
Prenatal Exposure to ADHD Meds Tied to Neonatal Morbidity

MONDAY, Nov. 13, 2017 (HealthDay News) -- Exposure to attention-deficit/hyperactivity disorder (ADHD) medication during pregnancy is associated with increased risk of neonatal morbidity, according to a study published online Nov. 10 in Pediatrics.

Ulrika Nörby, Ph.D., from Lund University in Sweden, and colleagues examined perinatal outcomes for singletons born between 2006 and 2014 in Sweden after maternal use of ADHD medication during pregnancy. Infants exposed to ADHD medication during pregnancy were compared with infants whose mothers never used these drugs and infants whose mothers used ADHD medication before or after pregnancy.

The researchers found that 0.2 percent of the 964,734 infants were exposed to ADHD medication during pregnancy and 1 percent had mothers treated before or after pregnancy. Compared with no use and use before or after pregnancy, exposure during pregnancy was correlated with increased risk for admission to a neonatal intensive care unit (adjusted odds ratios, 1.5 and 1.2, respectively). Compared with nonexposed infants, infants exposed during pregnancy more often had central nervous system-related disorders and were more often moderately preterm (adjusted odds ratios, 1.9 and 1.3, respectively). The risk for congenital malformations or perinatal death was not increased.

"Treatment with ADHD medication during pregnancy was associated with a higher risk for neonatal morbidity, especially central nervous system-related disorders such as seizures. Because of large differences in background characteristics between treated women and controls, it is uncertain to what extent this can be explained by the ADHD medication per se," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

NAFLD Linked to Smaller Total Cerebral Brain Volume

NAFLD Linked to Smaller Total Cerebral Brain Volume

Significant correlation even after adjustment for all covariates, including age, sex, alcohol consumption

Salivary miRNAs Can ID Duration of Concussion Symptoms

Salivary miRNAs Can ID Duration of Concussion Symptoms

Pediatric patients with prolonged symptoms were accurately identified by levels of five miRNAs

Treatment Trajectories Vary for Children With Depression

Treatment Trajectories Vary for Children With Depression

Most common class got psychotherapy monotherapy, and had lowest incidence of attempted suicide

is free, fast, and customized just for you!

Already a member?

Sign In Now »